Italy
· Delayed Price · Currency is EUR Mycronic AB Statistics
Total Valuation
Mycronic AB has a market cap or net worth of EUR 3.67 billion. The enterprise value is 3.42 billion.
| Market Cap | 3.67B |
| Enterprise Value | 3.42B |
Important Dates
The next estimated earnings date is Friday, July 11, 2025.
| Earnings Date | Jul 11, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
| Current Share Class | 97.92M |
| Shares Outstanding | n/a |
| Shares Change (YoY) | +0.02% |
| Shares Change (QoQ) | -0.01% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 75.10M |
Valuation Ratios
The trailing PE ratio is 21.95 and the forward PE ratio is 22.91.
| PE Ratio | 21.95 |
| Forward PE | 22.91 |
| PS Ratio | 5.30 |
| PB Ratio | 5.64 |
| P/TBV Ratio | 9.14 |
| P/FCF Ratio | 31.81 |
| P/OCF Ratio | 28.90 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 15.40, with an EV/FCF ratio of 29.60.
| EV / Earnings | 20.43 |
| EV / Sales | 4.96 |
| EV / EBITDA | 15.40 |
| EV / EBIT | 16.99 |
| EV / FCF | 29.60 |
Financial Position
The company has a current ratio of 2.52, with a Debt / Equity ratio of 0.03.
| Current Ratio | 2.52 |
| Quick Ratio | 1.77 |
| Debt / Equity | 0.03 |
| Debt / EBITDA | 0.09 |
| Debt / FCF | 0.17 |
| Interest Coverage | 146.07 |
Financial Efficiency
Return on equity (ROE) is 28.21% and return on invested capital (ROIC) is 20.55%.
| Return on Equity (ROE) | 28.21% |
| Return on Assets (ROA) | 14.00% |
| Return on Invested Capital (ROIC) | 20.55% |
| Return on Capital Employed (ROCE) | 28.30% |
| Revenue Per Employee | 298,504 |
| Profits Per Employee | 72,131 |
| Employee Count | 2,231 |
| Asset Turnover | 0.77 |
| Inventory Turnover | 1.79 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
| Beta (5Y) | n/a |
| 52-Week Price Change | n/a |
| 50-Day Moving Average | n/a |
| 200-Day Moving Average | n/a |
| Relative Strength Index (RSI) | 64.08 |
| Average Volume (20 Days) | 0 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Mycronic AB had revenue of EUR 691.93 million and earned 167.20 million in profits. Earnings per share was 1.71.
| Revenue | 691.93M |
| Gross Profit | 373.76M |
| Operating Income | 201.95M |
| Pretax Income | 207.57M |
| Net Income | 167.20M |
| EBITDA | 215.13M |
| EBIT | 201.95M |
| Earnings Per Share (EPS) | 1.71 |
Balance Sheet
The company has 275.59 million in cash and 19.72 million in debt, giving a net cash position of 255.87 million.
| Cash & Cash Equivalents | 275.59M |
| Total Debt | 19.72M |
| Net Cash | 255.87M |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 650.82M |
| Book Value Per Share | 6.67 |
| Working Capital | 391.08M |
Cash Flow
In the last 12 months, operating cash flow was 127.01 million and capital expenditures -11.61 million, giving a free cash flow of 115.40 million.
| Operating Cash Flow | 127.01M |
| Capital Expenditures | -11.61M |
| Free Cash Flow | 115.40M |
| FCF Per Share | n/a |
Margins
Gross margin is 54.02%, with operating and profit margins of 29.19% and 24.16%.
| Gross Margin | 54.02% |
| Operating Margin | 29.19% |
| Pretax Margin | 30.00% |
| Profit Margin | 24.16% |
| EBITDA Margin | 31.09% |
| EBIT Margin | 29.19% |
| FCF Margin | 16.68% |
Dividends & Yields
Mycronic AB does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | 24.31% |
| Buyback Yield | -0.02% |
| Shareholder Yield | -0.02% |
| Earnings Yield | 4.56% |
| FCF Yield | 3.14% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | n/a |